Faculty
Investigators of the CRISPR Cures for Cancer Initiative are conducting research at the intersection of genomic technologies and cellular immunotherapies at UC San Francisco, Gladstone Institutes, or the Innovative Genomics Institute at UC Berkeley.
Assistant Professor of Medicine,
UC San Francisco
​
​
President and Professor,
UCSF Helen Diller Family Comprehensive Cancer Center
​
Principal Investigator,
Innovative Genomics Institute
​
Assistant Professor of Medicine,
UC San Francisco
​
Affiliate Investigator,
Gladstone Institutes
​
.jpg)
Professor of Pharmaceutical Chemistry, UC San Francisco
​
​
​
Founder,
Innovative Genomics Institute
Professor of Chemistry and Molecular & Cell Biology,
UC Berkeley
Professor of Engineering,
UC Berkeley
Assistant Professor of Medicine,
UC San Francisco
Affiliate Investigator,
Gladstone Institutes
​
Assistant Professor of Anatomy,
UC San Francisco
​
​
​
Omar Khan, MD, PhD
Cellular Therapy & Transfusion Medicine Fellow, UC San Francisco
​
Hanqin Li, PhD
Principal Investigator,
Innovative Genomics Institute
​
​
​
Professor of Cellular and Molecular Pharmacology, UC San Francisco
​
Professor of Medicine,
UC San Francisco
​
Director and Senior Investigator, Gladstone-UCSF Institute of Genomic Immunology
​
​
Professor of Bioengineering,
UC Berkeley
​
​
​
Assistant Investigator,
Gladstone Institutes​
​
​
​
Associate Professor of Microbiology and Immunology, UC San Francisco
​
Affiliate Investigator,
Gladstone Institutes
​
Affiliate Investigator,
Gladstone-UCSF Institute of Genomic Immunology
​
Professor of Chemical & Biomolecular Imaging, UC Berkeley
​
Assistant Professor of Laboratory Medicine, UC San Francisco
​
​
Associate Professor of Otolaryngology-Head and Neck Surgery, UC San Francisco​
​
Associate Professor of Laboratory Medicine, UC San Francisco
​
​
​
Director of Therapeutic Delivery,
Innovative Genomics Institute
​
​
Associate Professor of Medicine, UC San Francisco
​